Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 55 Pharmacy (science) PhD Projects, Programmes & Scholarships

Discipline

Discipline

Medicine

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


Pharmacy (science) PhD Projects, Programmes & Scholarships

We have 55 Pharmacy (science) PhD Projects, Programmes & Scholarships

New Drugs for Brain Tumours: A Locoregional Implant Brain Tumours

  Research Group: Medicines Development and Pharmaceutical Sciences
Next-generation temozolomide derivatives for the treatment of high-grade glioma have been developed at the University of Bradford. Read more

Development of novel lipid nanoparticles (LNPs) for targeted gene delivery to cancer cells

Applications are invited for a self-funded, 3 year full-time PhD project. The PhD will be based in the School of Pharmacy and Biomedical Science and will be supervised by Dr Roja Hadianamrei and Dr Sassan Hafizi. Read more

Fully funded PhD position in Biopharmaceutical development for pulmonary delivery; Industrial Collaboration

This cross-disciplinary PhD project is between the School of Biomedical Science at UWL and the School of Pharmacy at UCL, and Pharmaceutical company to investigate the feasibility of developing an inhalation form of biotherapeutics for severe chronic inflammatory diseases. Read more

Inflammatory Arthritis in Childhood: Impact, Outcomes and Safety of Treatment

Juvenile Idiopathic Arthritis is the most common inflammatory arthritis of childhood. Although less common than arthritis in adults, a diagnosis of arthritis in a child can have lasting impacts on that child and their families through their entire lifespan. Read more

Development of multifunctional biomaterials for urinary catheters to eradicate catheter-associated urinary tract infections

Catheter-associated urinary tract infections (CAUTIs) are among the most common hospital-acquired infections worldwide threatening over 150 million people annually, imposing substantial burdens on the health system. Read more

Cell-matrix interface engineering for regenerative medicine applications and disease modelling

Dr. Mahetab Amer is seeking motivated students with backgrounds in tissue engineering, cell biology, materials science, or related fields to join her dynamic, multidisciplinary research group at the Division of Cell Matrix Biology and Regenerative Medicine, University of Manchester. Read more

Microneedle biosensors for rapid and painless disease diagnosis

This project aims to develop rapid disease diagnostics based on transdermal microneedle biosensors. Disease diagnosis often relies on invasive tissue sampling techniques, such as blood sampling or skin biopsies, in order to extract biomarkers for analysis. Read more

Biotherapeutic delivery through personalised 3D printed microneedle patches

Join our dynamic research team and be at the forefront of ground-breaking drug delivery advancements. We are offering a fully-funded 36 month PhD studentship (to UK students only) to tackle skin variability challenges through the development of personalised microneedles using cutting-edge 3D printing technology. Read more

Targeting the MAPK scaffold protein KSR1 for the treatment of prostate cancer

  Research Group: Institute of Cancer Therapeutics
Prostate cancer is one of the leading causes of male cancer deaths. It arises when individual cells escape their normal growth control mechanisms and proliferate in an uncontrolled fashion. Read more

Pharmacokinetics Guided Natural Products Exploration for Drug Discovery, Development, Delivery and Therapy

  Research Group: Institute of Cancer Therapeutics
Natural products have emerged as a key standard in novel and safe delivery of anticancer bioactive compounds. Apart from their ease of administration and delivery, natural/phytochemicals still face several hurdles, due to their physiochemical and pharmacokinetic properties. Read more

New Drugs for Brain Tumours: Prodrugs of Diazopropyne

  Research Group: Medicines Development and Pharmaceutical Sciences
The propargyl group, introduced to temozolomide-like drugs for brain tumours by our colleagues in Nottingham, shows considerable pre-clinical promise and… Read more

Design, synthesis and evaluation of protease-activated anti-cancer prodrugs

  Research Group: Institute of Cancer Therapeutics
Matrix metalloproteinases (MMPs) are a family of endoproteases that are overexpressed in tumours and play crucial roles in many tumourigenic processes, not least tumour invasion and angiogenesis. Read more

Filtering Results